1.0K(top 0.1%)
papers
78.1K(top 0.1%)
citations
128(top 0.1%)
h-index
244(top 0.1%)
g-index
1.1K
all documents
82.7K
doc citations
6.4K
citing journals

Top Articles

#TitleJournalYearCitations
1Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology20118,001
2Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing resultsMovement Disorders20084,796
3A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's diseaseAnnals of Neurology20031,450
4Astrocyte-Neuron Lactate Transport Is Required for Long-Term Memory FormationCell20111,285
5Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing planMovement Disorders20071,097
6Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task forceMovement Disorders2007885
7International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest studyMovement Disorders2006865
8Identification of a serotonin/glutamate receptor complex implicated in psychosisNature2008739
9Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect BehaviorNeuron2007692
10The Beclin 1–VPS34 complex – at the crossroads of autophagy and beyondTrends in Cell Biology2010687
11The scientific and clinical basis for the treatment of Parkinson disease (2009)Neurology2009685
12Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndromeNature2010672
13Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinomaNature1988629
14Understanding cell death in parkinson's diseaseAnnals of Neurology1998605
15Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trialLancet Neurology, The2010589
16An algorithm (decision tree) for the management of Parkinson’s disease (2001):Neurology2001565
17Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trialLancet Neurology, The2008529
18Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communicationMolecular Autism2010521
19Wdr5 Mediates Self-Renewal and Reprogramming via the Embryonic Stem Cell Core Transcriptional NetworkCell2011521
20Failure of the ubiquitin–proteasome system in Parkinson's diseaseNature Reviews Neuroscience2001490
21Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implicationsLancet Neurology, The2006461
22Fetal nigral transplantation as a therapy for Parkinson's diseaseTrends in Neurosciences1996455
23Accuracy and calibration of commercial oligonucleotide and custom cDNA microarraysNucleic Acids Research2002453
24Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhageCritical Care Medicine1999442
25Ambulatory monitoring of freezing of gait in Parkinson's diseaseJournal of Neuroscience Methods2008424
26Manganese-Induced Parkinsonism and Parkinson's DiseaseAnnals of the New York Academy of Sciences2004423
27Antiphospholipid Antibodies and Subsequent Thrombo-occlusive Events in Patients With Ischemic StrokeJAMA - Journal of the American Medical Association2004405
28Levodopa motor complications in Parkinson's diseaseTrends in Neurosciences2000393
29Formation and maintenance of Alzheimer's disease β-amyloid plaques in the absence of microgliaNature Neuroscience2009390
30Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystoniaNature Genetics2009384
31Cortical 5-HT2A Receptor Signaling Modulates Anxiety-Like Behaviors in MiceScience2006375
32Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusionsNeurobiology of Disease2009360
33A Phase 1/2 Clinical Trial of Enzyme Replacement in Fabry Disease: Pharmacokinetic, Substrate Clearance, and Safety StudiesAmerican Journal of Human Genetics2001350
34Subthalamic nucleus‐mediated excitotoxicity in parkinson's disease: A target for neuroprotectionAnnals of Neurology1998344
35Apoptosis in Parkinson's disease: Signals for neuronal degradationAnnals of Neurology2003337
36Levodopa in the treatment of Parkinson's disease: Current controversiesMovement Disorders2004331
37Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion‐Like Disorder?Movement Disorders2013320
38The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's diseaseScientific Data2018320
39Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice Is Eliminated by Familial Parkinson's Disease Mutation G2019SJournal of Neuroscience2010309
40Exome Sequencing Reveals De Novo WDR45 Mutations Causing a Phenotypically Distinct, X-Linked Dominant Form of NBIAAmerican Journal of Human Genetics2012309
41Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patientsTrends in Neurosciences1990304
42Interaction of the body, head, and eyes during walking and turningExperimental Brain Research2001299
43Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinatelyProceedings of the National Academy of Sciences of the United States of America2008288
44Accuracy assessment of the processed SRTM-based elevation data by CGIAR using field data from USA and Thailand and its relation to the terrain characteristicsRemote Sensing of Environment2006283
45Mutations in GNAL cause primary torsion dystoniaNature Genetics2013281
46Lewy-body formation is an aggresome-related process: a hypothesisLancet Neurology, The2004278
47Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic culturesJournal of Neurochemistry2002272
48Decoding the Signaling of a GPCR Heteromeric Complex Reveals a Unifying Mechanism of Action of Antipsychotic DrugsCell2011271
49Alloxan-induced diabetes—evidence for hydroxyl radical as a cytotoxic intermediateBiochemical Pharmacology1976254
50Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory CortexJournal of Neuroscience2003252